Azacitidine (Vidaza^®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015).

Published in:

Pediatric Drugs, 2023, v. 25, n. 6, p. 719, doi. 10.1007/s40272-023-00588-5

By:

• Rubio-San-Simón, Alba;
• van Eijkelenburg, Natasha K. A.;
• Hoogendijk, Raoull;
• Hasle, Henrik;
• Niemeyer, Charlotte M.;
• Dworzak, Michael N.;
• Zecca, Marco;
• Lopez-Yurda, Marta;
• Janssen, Julie M.;
• Huitema, Alwin D. R.;
• van den Heuvel-Eibrink, Marry M.;
• Laille, Eric J.;
• van Tinteren, Harm;
• Zwaan, Christian M.

Publication type:

Article